Hypertrophic scar Clinical Trials

12 recruitingLast updated: May 21, 2026

There are 12 actively recruiting hypertrophic scar clinical trials across 9 countries. Studies span Not Applicable, Phase 4, Early Phase 1, Phase 1, Phase 2, Phase 3. Top locations include Cairo, Egypt, Charleston, South Carolina, United States, Halifax, Nova Scotia, Canada. Updated daily from ClinicalTrials.gov.


Hypertrophic scar Trials at a Glance

12 actively recruiting trials for hypertrophic scar are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Cairo, Charleston, and Halifax. Lead sponsors running hypertrophic scar studies include Ankara Yildirim Beyazıt University, Centre Hospitalier Régional Metz-Thionville, and Al Hayah University In Cairo.

Browse hypertrophic scar trials by phase

About Hypertrophic scar Clinical Trials

Looking for clinical trials for Hypertrophic scar? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hypertrophic scar trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hypertrophic scar clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Phase 3

Topical Cryotherapy and Keloid/Hypertrophic Scars

hypertrophic scarsKeloid Scars
Sonal Choudhary30 enrolled1 locationNCT07336368
Recruiting
Not Applicable

Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy

MastectomyGender DysphoriaHypertrophic scar
University of California, San Francisco78 enrolled1 locationNCT07147166
Recruiting
Not Applicable

Efficacy in Preventing Hypertrophic Scars: A Randomised Controlled Trial Comparing Chitosan Cream, Silicone Gel & Olive Oil

hypertrophic scars
Universiti Sains Malaysia120 enrolled3 locationsNCT07269093
Recruiting
Phase 4

Remimazolam vs Propofol in Laser Burn Cases

Hypertrophic scarringProcedural SedationBurn scar
Medical University of South Carolina136 enrolled1 locationNCT07213544
Recruiting
Phase 1Phase 2

Evaluation of Clinical, Perceived and Instrumental Efficacy of a Scar Gel in Preventing Hypertrophic Scars

hypertrophic scarsSafety and EfficacyTopical Administration+3 more
Herbarium Laboratorio Botanico Ltda80 enrolled2 locationsNCT06751433
Recruiting
Early Phase 1

Zinc Oxide Versus Petrolatum Following Skin Surgery

ScarSurgical Site InfectionSurgery--Complications+3 more
Melissa Pugliano-Mauro30 enrolled1 locationNCT03561376
Recruiting
Phase 4

A clinical trial to compare efficacy of intralesional triamcinolone vs intralesional verapamil in patients with keloids/ hypertrophic scars.

hypertrophic scarskeloids
Noor ul Huda working as resident in khyber teaching hospital Peshawar.174 enrolled1 locationACTRN12625000568415
Recruiting
Not Applicable

Cost-Effectiveness of ESWT Plus Rehabilitation vs Rehabilitation Alone in Post-Burn Scars

Hypertrophic scar
Al Hayah University In Cairo104 enrolled1 locationNCT06913257
Recruiting
Not Applicable

Differential Pressure Distribution Orthosis by 3D Printing Process in the Treatment of Post-burn Hypertrophic Scarring

BurnsHypertrophic scar
Centre Hospitalier Régional Metz-Thionville25 enrolled1 locationNCT06487910
Recruiting
Not Applicable

Silicone Taping for the Improvement of Abdominal Donor Site Scars

ScarHypertrophic scar
Nova Scotia Health Authority32 enrolled1 locationNCT04506255
Recruiting
Not Applicable

Comparison of the Effects of Liquid Vaseline and Olive Oil on Itching and Scarring in Scald Burns

Hypertrophic scarringScald BurnItching
Ankara Yildirim Beyazıt University24 enrolled1 locationNCT06104540
Recruiting

The efficacy of adipose-derived stem cells as treatment of hypertrophic scar: a non-randomized controlled trial

Hypertrophic scar
Theddeus O. H. Prasetyono21 enrolled1 locationACTRN12622000619741